tiprankstipranks
Trending News
More News >
TG Therapeutics (TGTX)
NASDAQ:TGTX

TG Therapeutics (TGTX) Revenue

Compare
2,115 Followers

TG Therapeutics Revenue

TG Therapeutics had a revenue of 192.57M in the quarter ending Dec 31, 2025, with 19.09%. This bring the company's revenue in the last twelve months to 616.29M, Decreased 15.87%. In the fiscal year ending Dec 31, 2025, TG Therapeutics had annual revenue of 616.29M with 87.32% growth.
Revenue (ttm)
616.29M
Revenue Growth
100.88%
P/S Ratio
7.79
Revenue/Employee
$1,750,815
Employees
352
Market Cap
$4.80B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
616.29M287.28M+87.32%
Dec 31, 2024
329.00M95.34M+40.80%
Dec 31, 2023
233.66M230.88M+8,290.02%
Dec 31, 2022
2.79M-3.90M-58.36%
Dec 31, 2021
6.69M6.54M+4,300.66%
Dec 31, 2020
152.00K0.00
Dec 31, 2019
152.00K0.00
Dec 31, 2018
152.00K-381.00-0.25%
Dec 31, 2017
152.38K